At the time of writing, Elanco Animal Health Inc [ELAN] stock is trading at $22.08, down -1.82%. An important factor to consider is whether the stock is rising or falling in short-term value. The ELAN shares have gain 3.66% over the last week, with a monthly amount glided 3.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $30. Previously, KeyBanc Capital Markets started tracking the stock with Overweight rating on November 21, 2025, and set its price target to $27. On November 19, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $25 on the stock. JP Morgan upgraded its rating to an Overweight but stick to its price target of $24 on October 07, 2025. Leerink Partners upgraded its rating to an Outperform but $18 remained the price target by the analyst firm on July 17, 2025. William Blair upgraded its rating to Outperform for this stock on June 26, 2025. In a note dated December 09, 2024, UBS initiated a Buy rating and provided a target price of $18 on this stock.
For the past year, the stock price of Elanco Animal Health Inc fluctuated between $8.02 and $23.70. Currently, Wall Street analysts expect the stock to reach $24.75 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $22.08 at the most recent close of the market. An investor can expect a potential return of 12.09% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
According to Elanco Animal Health Inc [NYSE:ELAN], the company’s sales were 4.59B for trailing twelve months, which represents an 10.39% jump. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.83 points at the first support level, and at 21.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.50, and for the 2nd resistance point, it is at 22.93.
Ratios To Look Out For
It is important to note that Elanco Animal Health Inc [NYSE:ELAN] has a current ratio of 2.40. On the other hand, the Quick Ratio is 1.23, and the Cash Ratio is 0.35. Considering the valuation of this stock, the price to sales ratio is 2.39, the price to book ratio is 1.63 and price to earnings (TTM) ratio is 302.88.
Transactions by insiders
Recent insider trading involved Kurzius Lawrence Erik, Director, that happened on Dec 12 ’25 when 10000.0 shares were purchased. Modi Rajeev A. completed a deal on Dec 11 ’25 to buy 4500.0 shares. Meanwhile, EVP and CFO VanHimbergen Robert M bought 6950.0 shares on Dec 11 ’25.
